FAQs

This conference tells the narrative of the sample, from the moment it is collected to the second it is stored, and every detail in between.

That means this conference is perfect and curated for anyone working in a sample-intensive trial, and is dedicated to the core functions making this happen:

• Biomarker, Translational and/or Clinical Operations
• Biospecimen, Biosample, and/or Sample Management
• Vendor Management
• Translational Medicine
• Bioanalytical sciences

This is also highly relevant for vendors looking to provide solutions to these experts, so if you are with a CRO, diagnostic, central laboratory, sample tracking, LIM, or other relevant solutions.

While precision medicine conferences typically focus on scientific breakthroughs, biomarker discovery, clinical data and therapeutic development, the Biomarker Operations & Biospecimen Management Summit is dedicated to the operational backbone that makes those advances possible.

As the first event of its kind, this summit focuses exclusively on the teams responsible for managing samples and biomarker workflows across the clinical trial lifecycle.

From collection, shipping and chain of custody through to vendor oversight, sample tracking, analysis and long-term storage, every discussion is centred on the practical challenges of delivering high-quality biospecimen programs at scale.

Rather than treating biospecimen and biomarker operations as a small track within a larger meeting, we are placing these functions at the centre of the conversation, creating a dedicated forum for the professionals who ensure samples are fit-for-purpose, data is reliable, and trials stay on track.

100+ senior stakeholders from biopharma, labs, CROs and biobanks will unite at this meeting in November. With content spanning the complete lifecycle, you will meet with subject matter experts in kit design, site collection, tracking, storage, biobanking, lab coordination, data harmonization and more.

A sample of our current attendees:

• Large Pharma: AbbVie, Astellas Pharma, AstraZeneca, Bayer, BioNTech, Bristol Myers Squibb, Daiichi Sankyo, Eli Lilly, GSK, EMD Serono, Johnson & Johnson, Merck, Moderna, Novartis, Pfizer, Regeneron and Takeda.
• Biotech: Alexion Pharmaceuticals, Arcus Biosciences, Bicycle Therapeutics, Blueprint Medicines, Candel Therapeutics, Crescent Biopharma, Dyne Therapeutics, Incyte, Sarepta Therapeutics and Vertex Pharmaceuticals.
• Vendors: Almac, QuartzBio, Slope and TruTechnologies.

Request a sample blind attendee list here.

Registration for the meeting can be accessed through our registration portal here.

Conference attendance is complimentary* for eligible biopharma and research organizations. Due to the wealth of interest from your peers, complimentary* passes are now limited to a maximum of two per company.

Additional passes for other team members can be purchased through our registration portal.

Vendors and service and solution providers can purchase paid for tickets. We recommend registering as early as possible to make the most of our discounted rates.

If you’d like to discuss the summit in more detail or have any questions, please reach out to the event team.